Loading...
Home 2017-04-13T01:43:52+00:00

What do we do?

Our work allows cancer drugs to be efficiently produced, and delivered to cancerous tumors in a targeted fashion that doesn’t destroy the patient’s normal healthy cells indiscriminantly. We do this by simplifying and standardizing the production of antibody drug conjugates to treat cancer, using proprietary site-selective chemistries as protein modification technologies.

Who are we?

We are established scientists and medical professionals determined to treat people around world with superior, targeted cancer therapeutics.

Partnership opportunities

Leverage our novel chemistries to create your superior targeted therapeutics to treat cancer.

Investment opportunities

We have two parallel development paths: platform technology with the ability to be licensed by others and our own proprietary therapeutic products to treat cancer

Latest News and Events

ADVANCED PROTEOME THERAPEUTICS ANNOUNCES CLOSING OF SECOND TRANCHE OF AN OVER-SUBSCRIBED NON-BROKERED PRIVATE PLACEMENT

Vancouver, British Columbia / March 12, 2018 – Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSXV: APC) (FSE: 0E8) is pleased to announce that, further to its news release of March 5, 2018 and, due to high demand, it has closed a second tranche of its over-subscribed private placement [...]

March 13th, 2018|

We just moved into JLABS@Toronto

Advanced Proteome Therapeutics Corporation has offices in Canada at JLABS@Toronto and in Boston.